Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Benchmarking Trial Between France and Australia Comparing Management of Primary Rectal Cancer Beyond TME (Total Mesorectum Excision) and Locally Recurrent Rectal Cancer

NCT02551471 is registered in ClinicalTrials.gov with University Hospital, Bordeaux as lead sponsor.

NCT NCT02551471
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02551471 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Benchmarking Trial Between France and Australia Comparing Management of Primary Rectal Cancer Beyond TME (Total Mesorectum Excision) and Locally Recurrent Rectal Cancer
Lead sponsor
University Hospital, Bordeaux
Phase
Observational
Overall status
Completed
Start date
May 1, 2015
Completion date
July 31, 2018
Enrollment
165 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

rectal cancer